Literature DB >> 21293101

Coupling of α1-adrenoceptors to ERK1/2 in the human prostate.

Ricarda M Bauer1, Frank Strittmatter, Christian Gratzke, Johanna Göttinger, Boris Schlenker, Oliver Reich, Christian G Stief, Petter Hedlund, Karl-Erik Andersson, Martin Hennenberg.   

Abstract

INTRODUCTION: α1-Adrenoceptors are considered critical for the regulation of prostatic smooth muscle tone. However, previous studies suggested further α1-adrenoceptor functions besides contraction. Here, we investigated whether α1-adrenoceptors in the human prostate may activate extracellular signal-regulated kinases (ERK1/2).
METHODS: Prostate tissues from patients undergoing radical prostatectomy were stimulated in vitro. Activation of ERK1/2 was assessed by Western blot analysis. Expression of ERK1/2 was studied by immunohistochemistry. The effect of ERK1/2 inhibition by U0126 on phenylephrine-induced contraction was studied in organ-bath experiments.
RESULTS: Stimulation of human prostate tissue with noradrenaline (30 μM) or phenylephrine (10 μM) resulted in ERK activation. This was reflected by increased levels of phosphorylated ERK1/2. Expression of ERK1/2 in the prostate was observed in smooth muscle cells. Incubation of prostate tissue with U0126 (30 μM) resulted in ERK1/2 inhibition. Dose-dependent phenylephrine-induced contraction of prostate tissue was not modulated by U0126.
CONCLUSIONS: α1-Adrenoceptors in the human prostate are coupled to ERK1/2. This may partially explain previous observations suggesting a role of α1-adrenoceptors in the regulation of prostate growth.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293101     DOI: 10.1159/000322639

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  4 in total

1.  Factors influencing biased agonism in recombinant cells expressing the human α1A -adrenoceptor.

Authors:  Edilson Dantas da Silva Junior; Masaaki Sato; Jon Merlin; Natalie Broxton; Dana S Hutchinson; Sabatino Ventura; Bronwyn A Evans; Roger J Summers
Journal:  Br J Pharmacol       Date:  2017-06-10       Impact factor: 8.739

Review 2.  [Importance of adrenoceptor blockers and alpha reductase inhibitors : Monotherapy for treatment of benign prostate syndrome].

Authors:  F Strittmatter; S Madersbacher; C G Stief; C Gratzke
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

3.  Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle.

Authors:  Martin Hennenberg; Frank Strittmatter; Christer Beckmann; Beata Rutz; Claudius Füllhase; Raphaela Waidelich; Francesco Montorsi; Petter Hedlund; Karl-Erik Andersson; Christian G Stief; Christian Gratzke
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

4.  Pharmacology of the lower urinary tract.

Authors:  Martin Hennenberg; Christian G Stief; Christian Gratzke
Journal:  Indian J Urol       Date:  2014-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.